Stacy Markel - 23 Jun 2026 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
24 Jun 2026, 19:09:49 UTC
Prior SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Dang, Attorney-in-Fact, Attorney-in-Fact

Key filing fact

Stacy Markel filed Form 4 for Nuvation Bio Inc. (NUVB) on 24 Jun 2026.

Key facts

  • This page summarizes Stacy Markel's Form 4 filing for Nuvation Bio Inc. (NUVB).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 24 Jun 2026, 19:09.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$753,188.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001734780 Primary reporting owner

Markel Stacy

Relationship
CHIEF PEOPLE OFFICER
Address
C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK
Signature
/s/ Stephen Dang, Attorney-in-Fact, Attorney-in-Fact
Signature date
24 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+90,380
Change %
+277%
Price
$1.87*
Shares after
122,971
Date
23 Jun 2026
Ownership
Direct
NUVB transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+34,620
Change %
+28%
Price
$1.74*
Shares after
157,591
Date
23 Jun 2026
Ownership
Direct
NUVB transaction

Class A Common Stock

Sale

Transaction value
$753,188
Shares
-125,000
Change %
-79%
Price
$6.03
Shares after
32,591
Date
23 Jun 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-90,380
Change %
-18%
Price
$0.000000*
Shares after
409,620
Date
23 Jun 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
90,380
Exercise price
$1.87
Footnotes
F3
NUVB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-34,620
Change %
-14%
Price
$0.000000*
Shares after
220,190
Date
23 Jun 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
34,620
Exercise price
$1.74
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Shares sold pursuant to a 10b5-1 plan dated December 4, 2025.

Footnote F2

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.085. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Footnote F3

Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

Footnote F4

Option vests as to 25% on September 30, 2020 and in equal monthly installments thereafter over the following three years, subject to Reporting Person's continuous service on each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .